Opening calendar

Built by Radiologists.
Backed by Technology.

FDA 21 CFR Part 11 HIPAA GDPR PIPEDA AWS

Our Team

The People Behind the Platform.

Volumetryx was founded in 2024 by a team that saw the same problem in every early-stage oncology trial: sponsors paying for imaging infrastructure they couldn't access, control, or use.

We built BioSUITE because it didn't exist. A platform that gives early-stage oncology sponsors full control over their imaging data, with the depth of a specialized imaging CRO and none of the enterprise cost.

Vlad Cherniavsky

Vlad Cherniavsky

CEO & Co-founder

15+ years in business management. Builds the business engine behind Volumetryx.

LinkedIn
Kateryna Musaieva

Kateryna Musaieva

CMO & Co-founder

Expert radiologist leading all radiologic work. Sets state-of-the-art quality.

LinkedIn
Burkhan Musaiev

Burkhan Musaiev

VP Oncology Imaging & Co-founder

Oncology imaging expert. Designs advanced analysis protocols and quality standards.

LinkedIn
Ilya Kalyzhniuk

Ilya Kalyzhniuk

Co-founder

Drives commercial strategy and client relationships. Connects sponsors with the right solutions.

LinkedIn
Why Volumetryx

Built for Early-Stage
Oncology Trials

100%

DICOM Ownership

Full access to your imaging data. Export anytime, no lock-in, no per-download fees.

vs. reports only, pay to export
Days

Setup Time

Platform onboarded and collecting data within days. No months-long enterprise procurement.

vs. 3–6 months at traditional CROs
3D

Volumetric Analysis

MTV, TLG, viable tumor volume. Core service, ready in weeks — not an expensive add-on.

vs. expensive add-on, weeks to set up
24–72h

Read Turnaround

Blinded central reads by oncology subspecialists. Delivered in hours, not weeks.

vs. 1–4 weeks at traditional iCROs

Ready to Discuss Your Trial?

30-minute call. No commitment. Let's see if we're the right fit.

Book a Call
See It Live